ADC mapping of lymphomas and carcinomas in the nasopharynx and oropharynx

ADC Mapping (× 10−3 mm2/s)Percentage of Tumor Area on ADC Map
NasopharynxOropharynx
LymphomaNPCLymphomaPD SCCMD SCCWD SCC
T2 HomoT2 HeteroT2 HomoT2 Hetero
No. of patients781754357
Extremely low (<0.6)68 ± 1557 ± 1251 ± 35a,b,c,d34 ± 2510 ± 5a,b24 ± 2515 ± 13a,c15 ± 22a,d
Low (0.6–1.2)32 ± 1443 ± 1248 ± 3464 ± 2574 ± 775 ± 2668 ± 1863 ± 14
Intermediate (1.2–1.8)0 ± 01 ± 11 ± 2a,e,f1 ± 2a,g16 ± 10a,e,g2 ± 215 ± 19a,f19 ± 15
High (>1.8)0 ± 00 ± 00 ± 00 ± 00 ± 00 ± 02 ± 33 ± 5
  • Note:—PD, poorly differentiated, MD, moderately differentiated; Homo, homogeneous; Hetero, heterogeneous; WD, well-differentiated; T2 homo/hetero, with homogeneous/heterogeneous T2 signals.

  • a Significant differences between lymphomas and SCCs, and between PD SCCs with homogeneous T2 signals and heterogeneous T2 signals (Mann-Whitney U test).

  • b P = .040.

  • c P = .048.

  • d P = .011.

  • e P = .001.

  • f P < .001.

  • g P = .019.